HRP20020174A2 - Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same - Google Patents

Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same Download PDF

Info

Publication number
HRP20020174A2
HRP20020174A2 HR20020174A HRP20020174A HRP20020174A2 HR P20020174 A2 HRP20020174 A2 HR P20020174A2 HR 20020174 A HR20020174 A HR 20020174A HR P20020174 A HRP20020174 A HR P20020174A HR P20020174 A2 HRP20020174 A2 HR P20020174A2
Authority
HR
Croatia
Prior art keywords
methoxy
compounds
benzimidazole
methyl
sulfinyl
Prior art date
Application number
HR20020174A
Other languages
English (en)
Croatian (hr)
Inventor
R. Whittle Robert
Frederick
Walker Stowell Grayson
John Jenkins Douglas
Whittall Linda
Alan Meyer Glenn
Original Assignee
Aai Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/519,976 external-priority patent/US6262085B1/en
Application filed by Aai Pharma Inc filed Critical Aai Pharma Inc
Publication of HRP20020174A2 publication Critical patent/HRP20020174A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20020174A 1999-08-26 2000-08-25 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same HRP20020174A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15087899P 1999-08-26 1999-08-26
US09/519,976 US6262085B1 (en) 1999-08-26 2000-03-07 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
PCT/US2000/023363 WO2001014367A1 (en) 1999-08-26 2000-08-25 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Publications (1)

Publication Number Publication Date
HRP20020174A2 true HRP20020174A2 (en) 2005-12-31

Family

ID=26848119

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020174A HRP20020174A2 (en) 1999-08-26 2000-08-25 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Country Status (16)

Country Link
EP (1) EP1206466B1 (enExample)
JP (1) JP4312405B2 (enExample)
KR (1) KR100712039B1 (enExample)
CN (2) CN1183127C (enExample)
AT (1) ATE306483T1 (enExample)
AU (2) AU777667B2 (enExample)
BR (1) BR0014145A (enExample)
CA (1) CA2382867A1 (enExample)
DE (1) DE60023154T2 (enExample)
HR (1) HRP20020174A2 (enExample)
MX (1) MXPA02002007A (enExample)
NO (1) NO326849B1 (enExample)
RO (1) RO122491B1 (enExample)
RU (1) RU2263673C2 (enExample)
SI (1) SI20974A (enExample)
SK (1) SK286903B6 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
JP5457632B2 (ja) * 2004-06-24 2014-04-02 アストラゼネカ・アクチエボラーグ エソメプラゾールのナトリウム塩の製造に使用するための結晶の改変型の作成方法
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
CN103524491A (zh) * 2013-10-16 2014-01-22 江南大学 埃索美拉唑镁盐四水合物的三种晶型及其制备方法
US12366506B2 (en) * 2020-03-09 2025-07-22 Idexx Laboratories, Inc. Method for removing interfering components of a liquid sample prior to dispensing same on a chemical reagent test slide
CN114558004B (zh) * 2022-03-29 2023-08-11 奎马特里克斯有限公司 Qtx125药物制剂
CN116082247B (zh) * 2023-01-19 2025-08-01 浙江工业大学 一种苯并咪唑类衍生物及其应用
CN118225938B (zh) * 2024-04-02 2024-08-30 江苏海洋大学 一种中药复方五神汤的质量检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US895292A (en) * 1904-07-22 1908-08-04 Marvin A Neeland Blowing-engine inlet-valve.
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds

Also Published As

Publication number Publication date
RU2263673C2 (ru) 2005-11-10
DE60023154D1 (de) 2006-02-23
SK286903B6 (sk) 2009-07-06
NO20020914D0 (no) 2002-02-25
AU2005200203B2 (en) 2008-01-10
SI20974A (sl) 2003-02-28
MXPA02002007A (es) 2003-08-20
AU2005200203A1 (en) 2005-02-10
CA2382867A1 (en) 2001-03-01
JP2003507475A (ja) 2003-02-25
KR20020035861A (ko) 2002-05-15
DE60023154T2 (de) 2006-06-22
SK2812002A3 (en) 2002-07-02
AU777667B2 (en) 2004-10-28
NO326849B1 (no) 2009-03-02
CN1384831A (zh) 2002-12-11
CN1636564A (zh) 2005-07-13
EP1206466A1 (en) 2002-05-22
KR100712039B1 (ko) 2007-04-27
JP4312405B2 (ja) 2009-08-12
AU7073700A (en) 2001-03-19
CN1183127C (zh) 2005-01-05
ATE306483T1 (de) 2005-10-15
NO20020914L (no) 2002-04-26
RO122491B1 (ro) 2009-07-30
BR0014145A (pt) 2002-05-14
EP1206466B1 (en) 2005-10-12

Similar Documents

Publication Publication Date Title
US6667321B2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) Dry blend pharmaceutical formulations
WO2001014367A1 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) Pharmaceutical unit dosage form
US20100286400A1 (en) Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
US6326384B1 (en) Dry blend pharmaceutical unit dosage form
NO319719B1 (no) Kaliumsalt av (S)-omeprazol
HRP20020174A2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) Pharmaceutical unit dosage form
US6316020B1 (en) Pharmaceutical formulations
US6312712B1 (en) Method of improving bioavailability
EP1595879A2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
HK1085473A (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Legal Events

Date Code Title Description
A1OB Publication of a patent application
OBST Application withdrawn
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090803

Year of fee payment: 10